Risk factors for bacterial infections in HIV/hepatitis C virus-coinfected patients treated with interferon plus ribavirin

AIDS. 2008 Jul 11;22(11):1385-7. doi: 10.1097/QAD.0b013e328305bd8d.
No abstract available

Publication types

  • Letter
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Antiviral Agents / adverse effects*
  • Drug Therapy, Combination
  • Female
  • HIV Infections / complications
  • Hepatitis C, Chronic / drug therapy*
  • Humans
  • Interferon alpha-2
  • Interferon-alpha / adverse effects*
  • Male
  • Middle Aged
  • Opportunistic Infections / chemically induced*
  • Recombinant Proteins
  • Ribavirin / adverse effects*

Substances

  • Antiviral Agents
  • Interferon alpha-2
  • Interferon-alpha
  • Recombinant Proteins
  • Ribavirin